![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » COLLAGENEX REPORTS ALLOWANCE FOR PATENT ON ORACEA
COLLAGENEX REPORTS ALLOWANCE FOR PATENT ON ORACEA
CollaGenex Pharmaceuticals has announced that the U.S. Patent and Trademark Office has published on its website that U.S. patent application, serial no. 10/117,709, has been allowed.
This patent covers the use of subantimicrobial tetracyclines for treating acne and acne rosacea, including Oracea. CollaGenex submitted a new drug application for Oracea with the FDA on Aug. 1.
KEYWORDS Drug Pipeline Alert
Upcoming Events
-
21Oct